{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:46:23Z","timestamp":1792853183888,"version":"4.5.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T00:00:00Z","timestamp":1236211200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0004708","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T00:30:53Z","timestamp":1236213053000},"page":"e4708","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":268,"title":["Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya"],"prefix":"10.1371","volume":"4","clinical-trial-number":[{"clinical-trial-number":"nct00223990","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Bernhards R.","family":"Ogutu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odika J.","family":"Apollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willis","family":"Okoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joram","family":"Siangla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Dubovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Waitumbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter","family":"Diggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Wittes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa","family":"Malkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine A.","family":"Soisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica B.","family":"Milman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn A.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Polhemus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shon A.","family":"Remich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian F.","family":"Ockenhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Ripley","family":"Ballou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Angov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Ann","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Gray","family":"Heppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Withers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the MSP-1 Malaria Vaccine Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,3,5]]},"reference":[{"key":"ref1","first-page":"624","article-title":"Estimating mortality, morbidity and disability due to malaria among Africa&apos;s non-pregnant population.","volume":"77(8)","author":"RW Snow","year":"1999","journal-title":"Bull World Health Organ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4269\/ajtmh.2001.64.85","article-title":"The economic burden of malaria.","volume":"64","author":"JL Gallup","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4269\/ajtmh.2004.71.239","article-title":"Update on the clinical development of candidate malaria vaccines.","volume":"71","author":"WR Ballou","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS,S\/AS02A vaccine against <italic>Plasmodium falciparum<\/italic> infection and disease in young African children: randomised, controlled trial.","volume":"364","author":"PL Alonso","year":"2004","journal-title":"The Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(05)67669-6","article-title":"Duration of protection with RTS,S\/AS02A malaria vaccine in prevention of <italic>Plasmodium falciparum<\/italic> disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.","volume":"366","author":"PL Alonso","year":"2005","journal-title":"The Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0169-4758(93)90130-8","article-title":"The major merozoite surface protein as a malaria vaccine target.","volume":"9","author":"CL Diggs","year":"1993","journal-title":"Parasitol Today"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.vaccine.2005.01.142","article-title":"Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.","volume":"23(17\u201318)","author":"DG Heppner","year":"2005","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/expr.1996.0069","article-title":"<italic>Plasmodium knowlesi<\/italic>: Secondary processing of the malaria merozoite surface protein-1.","volume":"83","author":"MJ Blackman","year":"1996","journal-title":"Exp Parasitol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.180.1.389","article-title":"Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.","volume":"180","author":"MJ Blackman","year":"1994","journal-title":"J Exp Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1128\/IAI.72.10.6185-6189.2004","article-title":"The fine specificity, but not the invasion inhibitory activity, of 19-kilodalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in The Gambia.","volume":"72(10)","author":"PH Corran","year":"2004","journal-title":"Infect Immun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1128\/IAI.72.3.1557-1567.2004","article-title":"Fine specificity of serum antibodies to <italic>Plasmodium falciparum<\/italic> merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia.","volume":"72","author":"BA Okech","year":"2004","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/infdis\/173.3.765","article-title":"Clinical immunity to <italic>Plasmodium falciparum<\/italic> malaria is associated with antibodies to the 19-kDa C-terminal fragment of the merozoites surface antigen, PfMSP-1.","volume":"173","author":"AF Egan","year":"1996","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1073\/pnas.012590199","article-title":"A recombinant vaccine expressed in the milk of transgenic mice protects <italic>Aotus<\/italic> monkeys from a lethal challenge with <italic>Plasmodium falciparum<\/italic>.","volume":"99","author":"AW Stowers","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/IAI.73.1.287-297.2005","article-title":"Clinical grade <italic>Plasmodium falciparum<\/italic> FVO MSP1-42 expressed by <italic>Escherichia coli<\/italic> protects <italic>Aotus nancymai<\/italic> against homologous erythrocytic-stage challenge.","volume":"73(1)","author":"CA Darko","year":"2005","journal-title":"Infect Immun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/IAI.64.1.253-261.1996","article-title":"A recombinant baculovirus 42-kilodalton C-terminal fragment of <italic>Plasmodium falciparum<\/italic> merozoite surface protein 1 protects <italic>Aotus<\/italic> monkeys against malaria.","volume":"64","author":"SP Chang","year":"1996","journal-title":"Infect Immun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1086\/339342","article-title":"A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1\u20132b trial in Papua New Guinea.","volume":"185(6)","author":"B Genton","year":"2002","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(02)09784-2","article-title":"Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.","volume":"360(9333)","author":"DJ Pombo","year":"2002","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0166-6851(03)00077-X","article-title":"Development and pre-clinical analysis of a <italic>Plasmodium falciparum<\/italic> merozoite surface protein-1(42) malaria vaccine.","volume":"128","author":"E Angov","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.vaccine.2004.07.023","article-title":"Pre-clinical evaluation of the malaria vaccine candidate <italic>P. falciparum<\/italic> MSP1(42) formulated with novel adjuvants or with alum.","volume":"22","author":"S Pichyangkul","year":"2004","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1016\/j.vaccine.2005.11.028","article-title":"Phase I safety and immunogenicity trial of FMP1\/AS02A, a <italic>Plasmodium falciparum<\/italic> MSP-1 asexual blood stage vaccine.","volume":"24","author":"CF Ockenhouse","year":"2005","journal-title":"Vaccine"},{"key":"ref21","article-title":"Phase 1 randomized double-blind safety and immunogenicity trial of <italic>Plasmodium falciparum<\/italic> malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.","author":"JA Stoute","year":"2005","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1371\/journal.pctr.0010034","article-title":"Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: Results of a phase I randomized trial.","volume":"1(7)","author":"MA Thera","year":"2006","journal-title":"PLoS Clin Trials"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1371\/journal.pctr.0010032","article-title":"Safety and reactogenicity of an MSP_1 malaria vaccine candidate: A randomized phase Ib dose-escalation trial in Kenyan children.","volume":"24;1(7)","author":"MR Withers","year":"2006","journal-title":"PLoS Clin Trials"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4269\/ajtmh.1999.60.641","article-title":"Longitudinal cohort study of the epidemiology of malaria infections in an area of intense transmission II. Descriptive epidemiology of malaria infection and disease among children.","volume":"60(4)","author":"PB Bloland","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4269\/ajtmh.1994.50.529","article-title":"<italic>Plasmodium falciparum<\/italic> incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya.","volume":"50(5)","author":"JC Beier","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.4269\/ajtmh.2005.72.714","article-title":"Characterization of a human reference standard for antibody to <italic>Plasmodium falciparum<\/italic> merozoite surface protein 1(42).","volume":"72(6)","author":"IK Yoon","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0035-9203(00)90300-6","article-title":"Severe falciparum malaria.","volume":"94","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0035-9203(95)90106-X","article-title":"Acquired antibody levels to <italic>Plasmodium falciparum<\/italic> merozoite surface antigen 1 in residents of a highly endemic area of Papua New Guinea.","volume":"89","author":"F al-Yaman","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4269\/ajtmh.1996.54.443","article-title":"Assessment of the role of naturally acquired antibody levels to <italic>Plasmodium falciparum<\/italic> merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.","volume":"54","author":"F al-Yaman","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/IAI.64.7.2716-2723.1996","article-title":"Natural immune response to the C-terminal 19-kilodalton domain of <italic>Plasmodium falciparum<\/italic> merozoite surface protein 1.","volume":"64","author":"YP Shi","year":"1996","journal-title":"Infect Immun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4269\/ajtmh.2002.66.461","article-title":"Association of the IgG response to <italic>Plasmodium falciparum<\/italic> merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region.","volume":"66","author":"EM Braga","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1084\/jem.186.10.1689","article-title":"Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies.","volume":"186(10)","author":"JA Guevara Patino","year":"1997","journal-title":"J Exp Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0004708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T09:20:56Z","timestamp":1589620856000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0004708"}},"subtitle":[],"editor":[{"given":"James G.","family":"Beeson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,3,5]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,3,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0004708","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,5]]}}}